SPOTLIGHT: Medtronic to shed 1,100 jobs

Stalling sales of implantable defibrillators have prompted device maker Medtronic to cut 1,100 jobs; that's on top of 900 positions cut last year. The company employs nearly 40,000 total. Report | Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.